BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36511953)

  • 1. [Clostridioides difficile: updated recommendations].
    Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
    Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clostridium difficile colitis].
    Eckert C; Lalande V; Barbut F
    Rev Prat; 2015 Jan; 65(1):21-5. PubMed ID: 25842418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
    van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
    Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clostridioides difficile - New Insights and Therapy Recommendations].
    Schönherr S; Jung L; Lübbert C
    Dtsch Med Wochenschr; 2023 Jun; 148(12):752-758. PubMed ID: 37257477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).
    Bouza E; Aguado JM; Alcalá L; Almirante B; Alonso-Fernández P; Borges M; Cobo J; Guardiola J; Horcajada JP; Maseda E; Mensa J; Merchante N; Muñoz P; Pérez Sáenz JL; Pujol M; Reigadas E; Salavert M; Barberán J
    Rev Esp Quimioter; 2020 Apr; 33(2):151-175. PubMed ID: 32080996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating changes in
    Durham SH; Le P; Cassano AT
    J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
    [No Abstract]   [Full Text] [Related]  

  • 7. Enterotoxic Clostridia:
    Mileto S; Das A; Lyras D
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31124432
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Costa DVS; Pham NVS; Hays RA; Bolick DT; Goldbeck SM; Poulter MD; Hoang SC; Shin JH; Wu M; Warren CA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0048922. PubMed ID: 35861541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridioides difficile Colitis.
    Pumiglia L; Wilson L; Rashidi L
    Surg Clin North Am; 2024 Jun; 104(3):545-556. PubMed ID: 38677819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
    Yakout A; Bi Y; Harris DM
    J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of
    Oksi J; Anttila VJ; Mattila E
    Ann Med; 2020; 52(1-2):12-20. PubMed ID: 31801387
    [No Abstract]   [Full Text] [Related]  

  • 13. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.
    Cymbal M; Chatterjee A; Baggott B; Auron M
    Am J Med; 2024 Jul; 137(7):571-576. PubMed ID: 38508330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutics for
    Khanna S; Voth E
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):903-911. PubMed ID: 37606962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
    Rajasingham R; Enns EA; Khoruts A; Vaughn BP
    Clin Infect Dis; 2020 Feb; 70(5):754-762. PubMed ID: 31001619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to: Clostridioides difficile infection in children.
    Krutova M; de Meij TGJ; Fitzpatrick F; Drew RJ; Wilcox MH; Kuijper EJ
    Clin Microbiol Infect; 2022 Aug; 28(8):1085-1090. PubMed ID: 35283312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
    Krutova M; Wilcox M; Kuijper E
    Int J Infect Dis; 2022 Nov; 124():118-123. PubMed ID: 36155825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.